BIOMAT Database Logo BIOMAT Database Logo

Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases. 2003

Chandrasekharam N Nagineni, and William Samuel, and Sahrudaya Nagineni, and Komanduri Pardhasaradhi, and Barbara Wiggert, and Barbara Detrick, and John J Hooks
National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Vascular endothelial growth factor (VEGF) is a major agent in choroidal and retinal neovascularization, events associated with age-related macular degeneration (AMD) and diabetic retinopathy. Retinal pigment epithelium (RPE), strategically located between retina and choroid, plays a critical role in retinal disorders. We have examined the effects of various growth factors on the expression and secretion of VEGF by human retinal pigment epithelial cell cultures (HRPE). RT-PCR analyses revealed the presence of three isoforms of mRNA corresponding to VEGF 121, 165, and 189 that were up regulated by TGF-beta1. TGF-beta1, beta2, and beta3 were the potent inducers of VEGF secretion by HRPE cells whereas bFGF, PDGF, TGF-alpha, and GM-CSF had no effects. TGF-beta receptor type II antibody significantly reversed induction of VEGF secretion by TGF-beta. In contrast activin, inhibin and BMP, members of TGF-beta super family, had no effects on VEGF expression in HRPE. VEGF mRNA levels and protein secretion induced by TGF-beta were significantly inhibited by SB203580 and U0126, inhibitors of MAP kinases, but not by staurosporine and PDTC, protein kinase C and NF-kappaB pathway inhibitors, respectively. TGF-beta also induced VEGF expression by fibroblasts derived from human choroid of eye. TGF-beta induction of VEGF secretion by RPE and choroid cells may play a significant role in choroidal neovascularization (CNV) in AMD. Since the secretion of VEGF by HRPE is regulated by MAP kinase pathways, MAP kinase inhibitors may have potential use as therapeutic agents for CNV in AMD.

UI MeSH Term Description Entries
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D010857 Pigment Epithelium of Eye The layer of pigment-containing epithelial cells in the RETINA; the CILIARY BODY; and the IRIS in the eye. Eye Pigment Epithelium
D012164 Retinal Diseases Diseases involving the RETINA. Disease, Retinal,Diseases, Retinal,Retinal Disease
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002829 Choroid The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA. Choriocapillaris,Haller Layer,Haller's Layer,Sattler Layer,Sattler's Layer,Choroids
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Chandrasekharam N Nagineni, and William Samuel, and Sahrudaya Nagineni, and Komanduri Pardhasaradhi, and Barbara Wiggert, and Barbara Detrick, and John J Hooks
Hyperthermia-induced upregulation of vascular endothelial growth factor in retinal pigment epithelial cells is regulated by mitogen-activated protein kinases.
November 2014, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Chandrasekharam N Nagineni, and William Samuel, and Sahrudaya Nagineni, and Komanduri Pardhasaradhi, and Barbara Wiggert, and Barbara Detrick, and John J Hooks
Transforming growth factor beta induces urokinase receptor expression in cultured retinal pigment epithelial cells.
January 1999, Ophthalmic research,
Chandrasekharam N Nagineni, and William Samuel, and Sahrudaya Nagineni, and Komanduri Pardhasaradhi, and Barbara Wiggert, and Barbara Detrick, and John J Hooks
Transforming growth factor-beta 1 induces vascular endothelial growth factor expression in murine proximal tubular epithelial cells.
January 2003, Nephron. Experimental nephrology,
Chandrasekharam N Nagineni, and William Samuel, and Sahrudaya Nagineni, and Komanduri Pardhasaradhi, and Barbara Wiggert, and Barbara Detrick, and John J Hooks
Progesterone induces vascular endothelial growth factor on retinal pigment epithelial cells in culture.
January 1996, Life sciences,
Chandrasekharam N Nagineni, and William Samuel, and Sahrudaya Nagineni, and Komanduri Pardhasaradhi, and Barbara Wiggert, and Barbara Detrick, and John J Hooks
Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase.
August 2002, Surgery,
Chandrasekharam N Nagineni, and William Samuel, and Sahrudaya Nagineni, and Komanduri Pardhasaradhi, and Barbara Wiggert, and Barbara Detrick, and John J Hooks
Activated blood coagulation factor X (FXa) induces angiogenic growth factor expression in human retinal pigment epithelial cells.
August 2012, Investigative ophthalmology & visual science,
Chandrasekharam N Nagineni, and William Samuel, and Sahrudaya Nagineni, and Komanduri Pardhasaradhi, and Barbara Wiggert, and Barbara Detrick, and John J Hooks
Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.
April 2003, Biochemical and biophysical research communications,
Chandrasekharam N Nagineni, and William Samuel, and Sahrudaya Nagineni, and Komanduri Pardhasaradhi, and Barbara Wiggert, and Barbara Detrick, and John J Hooks
Identification of transforming growth factor-beta expressed in cultured human retinal pigment epithelial cells.
February 1993, Investigative ophthalmology & visual science,
Chandrasekharam N Nagineni, and William Samuel, and Sahrudaya Nagineni, and Komanduri Pardhasaradhi, and Barbara Wiggert, and Barbara Detrick, and John J Hooks
RNA interference inhibits expression of vascular endothelial growth factor (VEGF) in human retinal pigment epithelial cells.
November 2005, Chinese medical journal,
Chandrasekharam N Nagineni, and William Samuel, and Sahrudaya Nagineni, and Komanduri Pardhasaradhi, and Barbara Wiggert, and Barbara Detrick, and John J Hooks
Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta.
May 1994, Journal of cellular physiology,
Copied contents to your clipboard!